Skip to main content
Caplight Logo









CuraFi

CuraFi

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://curafi.com/

Last Round

Seed

Mar 1, 2023

Total Funding Raised

$7.25M

Company Overview

CuraFi operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in March 2023.

CuraFi is a software company that provides an AI-powered platform to help healthcare organizations manage and lower drug costs.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Vertical SaaS, Workflow Automation, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CuraFi Comparables

Compare CuraFi with similar companies based on industry and business-model similarity.

CuraFi comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
InfuseFlow
86%
House Rx
83%
WeInfuse
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CuraFi Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 1, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

CuraFi Investors

Notable investors and investment history

CuraFi investors
InvestorRounds
Boutique Venture PartnersSeed
AV8 VenturesSeed
Tau VenturesSeed
Max VenturesSeed
Candy VCSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 49% MoM, reaching 3.5K.

  • Apr 16, 2026

    Monthly visitors increased 31% MoM, reaching 2.9K.

Book a demo to see all signals

For institutional investors. Book with your work email.

CuraFi Filings

Explore SEC and related filing metadata, where available.

CuraFi filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CuraFi's valuation, stock price, and market status.

Is CuraFi a public or private company?

CuraFi is a private company.

What is the current stock price of CuraFi?

CuraFi is a private company, so its shares have no public market price. Caplight tracks CuraFi's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CuraFi worth (valuation)?

Valuation information for CuraFi is not publicly available.

Can I buy CuraFi stock?

CuraFi shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CuraFi's last funding round?

CuraFi's most recent funding round was Seed on March 1, 2023.

Who are the main investors in CuraFi?

Key investors in CuraFi include Boutique Venture Partners, AV8 Ventures, Tau Ventures, Max Ventures, Candy VC.

Will CuraFi IPO soon?

No public IPO plans have been announced for CuraFi.

How can I track CuraFi secondary market activity?

Caplight tracks bids, offers, and trades in CuraFi's shares on secondary markets.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range16
Year Founded2022
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?